go-v.orgdoi

Beta-Blocker Evaluation in Survival Trial (BEST)

BioLINCC (a data-sharing platform funded by the National Institutes of Health) · Vivli · 2018

  • DOI 10.25934/00000025
  • Publisher Vivli
  • Type dataset
  • Issued 2018

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Vivli · Vivli · dataset · 2018

Abstract

To determine if addition of a beta-blocker to standard therapy in Class III and Class IV heart failure patients reduced total mortality.

Open the resolved locator · 10.25934/00000025

Metadata licence: OpenAlex metadata (CC0)